ARTICLES

Sleep to Overnight Clearing of Alzheimer's-Linked Proteins
Research & Studies

Study Links Sleep to Overnight Clearing of Alzheimer’s-Linked Proteins

What if sleep could help prevent Alzheimer’s disease? A new landmark study by researchers at Applied Cognition, a clinical-stage therapeutic company, points to the brain’s glymphatic system, its fluid-based “clean-up” pathway, as a key driver of overnight clearance of Alzheimer’s-linked proteins. The researchers found that during normal sleep, levels of amyloid beta and […]

techno xperts julia sarmiento
Diagnostics & Testing Product & Vendor Updates

Techno Xperts Builds Sleep Diagnostics Distribution Platform for Latin America

After more than two decades in the global sleep medicine industry, Julia Sarmiento, former Director of Sales of the Americas for SOMNOmedics US, has launched and rapidly expanded Techno Xperts, a dedicated distribution platform serving Latin America. The company was established to increase access to advanced sleep diagnostics technologies while […]

Clear Chronic Care Expands National Footprint as Medicare Infrastructure Partner for RPM, CCM and Quality Performance; Enters Sleep Medicine Market
Industry News & Updates

Clear Chronic Care Expands Nationally, Enters Sleep Medicine Market

Clear Chronic Care announced continued national expansion of its Medicare-focused Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform, reinforcing its position as a long-term infrastructure partner to physician practices navigating value-based reimbursement. The company also announced strategic expansion into sleep medicine, where chronic oversight and adherence management are […]

ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
Industry News & Updates

ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine

ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]

Harmony Biosciences Receives U.S. FDA Approval for WAKIX (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
Narcolepsy Sleep Pharmaceuticals

Harmony Biosciences Receives FDA Approval for WAKIX for the Treatment of Cataplexy in Pediatric Narcolepsy

Harmony Biosciences announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for WAKIX® (pitolisant) tablets for the treatment of cataplexy in pediatric patients 6 years of age and older with narcolepsy. WAKIX is now the first-and-only FDA-approved non-scheduled treatment for pediatric and adult […]

Alkermes Avadel Aquisition
Industry News & Updates Sleep Pharmaceuticals

Alkermes Completes Acquisition of Avadel, Accelerating Entry Into Sleep Medicine Market

Alkermes plc and Avadel Pharmaceuticals plc, announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep […]